Actionable news
0
All posts from Actionable news
Actionable news in BMY: BRISTOL-MYERS SQUIBB CO.,

Hep C Business Slow-Down Could Hamper Bristol-Myers' Future

Bristol-Myers Squibb's (BMY) shares fell 2% Thursday thanks to investor doubts that its hepatitis C drug division can maintain the banner levels of sales growth posted in the second quarter.

Bristol was trading at $75.14 per share midday Thursday, down 1.75% from market's open.

The New York-based company's hepatitis C franchise raked in $546 million in revenue for the three months ending June 30, an increase of 14% compared to the second quarter of 2015.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks with serious upside...


More